Sphera Funds Management’s Sage Therapeutics SAGE Stock Holding History

Sphera Funds Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-128,000	Closed	-$6.02M	–	100
2023 Q2	$6.02M	Sell	128,000 -27,000	-17%	-$1.34M	0.94%	42
2023 Q1	$6.5M	Buy	+155,000	New	+$6.66M	1.09%	30
2021 Q1	–	Sell	-8,554	Closed	-$740K	–	197
2020 Q4	$740K	Buy	+8,554	New	+$630K	0.07%	102
2019 Q1	–	Sell	-103,500	Closed	-$9.91M	–	116
2018 Q4	$9.91M	Buy	103,500 +43,500	+73%	+$4.98M	1.12%	24
2018 Q3	$8.47M	Buy	+60,000	New	+$9.26M	0.97%	24
2018 Q1	–	Sell	-30,000	Closed	-$4.94M	–	136
2017 Q4	$4.94M	Buy	30,000 +23,882	+390%	+$2.32M	0.58%	41
2017 Q3	$381K	Buy	6,118 +1,118	+22%	+$87.8K	0.05%	114
2017 Q2	$398K	Sell	5,000 -45,000	-90%	-$3.25M	0.07%	113
2017 Q1	$3.55M	Sell	50,000 -40,000	-44%	-$2.34M	0.69%	41
2016 Q4	$4.59M	Sell	90,000 -69,500	-44%	-$3.28M	1.16%	19
2016 Q3	$7.34M	Buy	159,500 +90,000	+129%	+$3.66M	1.2%	19
2016 Q2	$2.09M	Sell	69,500 -53,500	-43%	-$1.78M	0.54%	58
2016 Q1	$3.94M	Buy	123,000 +30,000	+32%	+$1.06M	0.85%	20
2015 Q4	$5.42M	Buy	93,000 +85,000	+1,063%	+$4.21M	0.79%	20
2015 Q3	$339K	Sell	8,000 -40,000	-83%	-$2.47M	0.04%	124
2015 Q2	$3.5M	Sell	48,000 -17,724	-27%	-$1.14M	0.34%	70
2015 Q1	$3.3M	Sell	65,724 -14,000	-18%	-$602K	0.34%	71
2014 Q4	$2.92M	Sell	79,724 -8,200	-9%	-$306K	0.5%	66
2014 Q3	$2.77M	Buy	+87,924	New	+$2.55M	0.34%	72

Other funds holding SAGE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sphera Funds Management's SAGE Position: Q3 2023 in Review

Sphera Funds Management sold out of Sage Therapeutics (SAGE) in Q3 2023, closing a stake of 128,000 shares — an estimated $6.02M sold.

Sphera Funds Management first reported a position in SAGE in Q3 2014 and held it in 19 quarters. The position peaked at $9.91M in Q4 2018. 194 funds tracked by Wall St. Rank hold SAGE as of Q3 2023.

Sphera Funds Management reported no remaining Sage Therapeutics position as of Q3 2023 after selling out during the quarter.
Sphera Funds Management sold 128,000 Sage Therapeutics shares in Q3 2023, an estimated $6.02M.
Sphera Funds Management first reported a position in Sage Therapeutics in Q3 2014 and held it in 19 quarters.
Sphera Funds Management's Sage Therapeutics position peaked at $9.91M in Q4 2018.
194 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2023.

Based on Sphera Funds Management's 13F filing for Q3 2023, filed 14 Nov 2023.